BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

GlaxoSmithKline (GSK) Shares Drop on Q1 Disappointment


4/26/2012 6:53:52 AM

GlaxoSmithKline, the London-based pharmaceuticals and consumer goods company, reported Wednesday a 13 percent drop in first-quarter net profit compared with a year earlier, when earnings were heavily boosted by the sale of a unit. Shares in the company fell 2.4 percent at 1,422 pence as its results were weaker than anticipated. GlaxoSmithKline PLC said profit after tax was 1.325 billion pounds ($2.1 billion), down from 1.525 billion pounds a year earlier. Profit in the first quarter of 2011 was boosted by the 1.2 billion-pound sale of the company's stake in Quest, a U.S. medical lab operator, and its North American interests in Zovirax cold sore cream.

Read at BusinessWeek
Read at Daily Finance
Read at AFP

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->